Akero Therapeutics, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Akero Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Akero Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -29.9 %, a 25.2% decline year-over-year.
  • Akero Therapeutics, Inc. annual Return On Assets for 2023 was -27.2 %, a 33.6% increase from 2022.
  • Akero Therapeutics, Inc. annual Return On Assets for 2022 was -41.1 %, a 6.83% increase from 2021.
  • Akero Therapeutics, Inc. annual Return On Assets for 2021 was -44.1 %, a 13.2% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -27.2 +13.8 +33.6% Jan 1, 2023 Dec 31, 2023
2022 -41.1 +3.01 +6.83% Jan 1, 2022 Dec 31, 2022
2021 -44.1 -5.15 -13.2% Jan 1, 2021 Dec 31, 2021
2020 -38.9 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.